2 Top Growth Stocks to Buy in January

Dye & Durham (TSX:DND) and Tecsys (TSX:TCS) are two top growth stocks to buy during the first month of 2022.

| More on:
growing plant shoots on stacked coins

Image source: Getty Images

If you want to start 2022 on the right foot financially, Dye & Durham (TSX:DND) and Tecsys (TSX:TCS) are two growth stocks that should perform well in January.

Dye & Durham

Dye & Durham provides cloud-based information services and workflow solutions to legal, government, and financial services firms. The company’s strategy is to grow through acquisitions that immediately generate profits.

As Dye & Durham works in a niche market, it doesn’t worry about too much competition. The company also showed strength when it rejected a takeover bid to privatize the company. Dye & Durham continued with its existing business strategy of growth through acquisitions as it believes this strategy can deliver shareholder value. The efficient execution of all acquisitions by the company makes it one of the best growth stocks to buy and hold forever.

The company posted better-than-expected results for the first fiscal quarter of 2022. Revenue and adjusted EBITDA increased 414% and 398%, respectively, with net income of $22.1 million. The strong results underscore the breadth and pace of Dye & Durham’s underlying growth.

Dye & Durham has signed an agreement to purchase Telus Financial Solutions for $500 million. This acquisition should go a long way in strengthening its digital infrastructure.

The company also signed a deal to acquire Link Group, a technology-driven market leader that connects people to their assets for $3.2 billion. The acquisition confirms the company’s ambition to achieve $1 billion in adjusted EBITDA.

Its diverse customer base, high retention rate, geographic expansion and long-term contracts with top clients will support its growth. In addition, its strong M&A pipeline and strong balance sheet will likely accelerate its rate of growth.

Tecsys

Another growth stock that deserves a mention is Tecsys. Tecsys develops and sells end-to-end supply chain management software solutions. Thus, the company is right in the “sweet spot” with all of the current supply chain issues.

Its main clients are health networks in the United States a vertical that it dominates. It also serves businesses with complex distribution needs, like wholesaling and transportation logistics, as well as retailers with omnichannel sales.

The company just reported another quarter of record sales with high-margin SaaS recurring revenue growth and has a record backlog.

Tecsys had its 11th consecutive quarter of record revenue at $34.3 million, up 12% year over year. SaaS revenue increased 28% to $6.6 million, while subscription bookings was up 50% to $4 million. Professional services revenue was up 11% to $13.1 million.

Peter Brereton, president and CEO, said in a press release: “Our three target verticals are all performing or outperforming expectations, with notable wins in healthcare with three new major hospital networks, and an expanding customer base in global retail and our distribution market. We are confident that we are favourably positioned as the heightened focus on supply chains turns into greater investment in supply chain agility and the specialized technologies that underpin it.”

The company just reported another quarter of record results and record backlog, and the pullback represents a tremendous buying opportunity

Tecsys has been included in the TSX30 for 2021, which recognizes the 30 top-performing stocks over the past three years. 

Tecsys’ dividend yield of around 0.5% is low, but it’s a Canadian Dividend Aristocrat. Specifically, the growth stock has increased its dividend for 13 consecutive years.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Stephanie Bedard-Chateauneuf has no position in any of the stocks mentioned. The Motley Fool owns and recommends Tecsys Inc.

More on Tech Stocks

healthcare pharma
Tech Stocks

Well Health Stock Is Up 7% After Earnings: What Investors Need to Know

Well Health is benefiting from strong demand as it digitizes healthcare and strives to improve patient outcomes.

Read more »

Circuit board with a microchips
Tech Stocks

1 AI Stock That Can Help Turbocharge Your TFSA

Docebo is a high-flying growth stock that operates in the AI space and is a top investment in May 2024.

Read more »

Businessman holding AI cloud
Tech Stocks

This Canadian AI Stock Is Growing at a Breakneck Pace

Canadian AI stock Kinaxis Inc (TSX:KXS) is giving U.S. giants a run for their money.

Read more »

grow dividends
Tech Stocks

Why Hut Stock Surged 11% on Wednesday

Hut 8 (TSX:HUT) stock surged by as much as 11% on Wednesday after strong earnings that delivered on finances and…

Read more »

sad concerned deep in thought
Tech Stocks

The Potential TikTok Ban in the U.S. Is Real: Here’s What it Means for Facebook’s Stock

Meta Platforms (NASDAQ:META) could gain market share from TikTok being banned. That might leave BCE Inc (TSX:BCE) in a bad…

Read more »

Hand arranging wood block stacking as step stair with arrow up.
Tech Stocks

Lightspeed Stock Jumps 15% on Founder Dasilva’s Return, Earnings Beat

Dax DaSilva is back as Lightspeed stock (TSX:LSPD) CEO, and investors were thrilled with the news, along with a 25%…

Read more »

A gamer uses goggles to play an augmented reality game. tech
Tech Stocks

Why ‘Roaring Kitty’ Sent Meme Stocks Soaring Like It’s 2021

Roaring Kitty came back, leading to another rally in meme stocks that could be over before it even gets started.

Read more »

value for money
Tech Stocks

3 Bargains I’d Snatch Up as They Approach 52-Week Lows

Despite their near-term weakness, these three bargain stocks are excellent buys at these levels.

Read more »